Why we need artificial pancreas
A study by Bode et al., 2005 showed that even in patients who check blood glucose regularly, less than 30 % of their time is spent in the normal glucose range. The constant fear of hypoglycemia makes the patient or their caregivers to allow blood sugar levels to reach a high value. Regular blood sugar monitoring and insulin injections are time-consuming and troublesome.
Thus, the development of an artificial pancreas could dramatically improve diabetes care and management and reduce the risk of potential diabetic complications.
Towards achieving this goal, researchers have developed the artificial pancreas. This is of two types, the mechanical artificial pancreas, and the bio-artificial or biohybrid artificial pancreas (BHAP).
The development of artificial pancreas
The mechanical artificial pancreas (Medtronic) is made up of the sensor (A) to detect blood sugar levels, a computer programme (B) to determine the amount of insulin required, and an insulin pump (C) to pump insulin into the body. This is a "closed-loop" device. With a perfect computer algorithm, the glucose sensor can literally "talk" to the insulin pump to secrete the required insulin.The sensor is implanted under the skin of the abdomen or threaded to the large vein of the heart (vena cava). However, there are problems with such a mechanical artificial pancreas:
1. The sensor needs to be recalibrated to correct values and replaced periodically.
2. A "perfect" computer algorithm, which could deliver the correct insulin dose, has not yet been developed.
3. A stable, sensitive, and accurate sensor has not yet been developed.
4. Any kind of error in sensing, computation or delivery of insulin could lead to weight gain or worse, to life-threatening hypoglycemia.
5. There might not be a swift response to changes in blood sugar like the normal pancreas.
In order to address these difficulties, researchers have tried to adopt a less mechanical and more biological approach. The outcome has been the bio-artificial pancreas or biohybrid artificial pancreas (BHAP), composed of both biological and nonbiological components. While the biological component consists of islets of Langerhans that sense glucose levels and secrete appropriate amount of insulin, the nonbiological component (microcapsules fabricated with alginate-based polymers) protects the islets from rejection by the body. A BHAP is implanted into the peritoneal cavity and contains 2-3 million islet cells.
The most encouraging research data have come from such passive diffusion devices that cause no rejection, and allows passive diffusion of oxygen, glucose, and other nutrients in, and insulin and other hormones outside the device.
However, more studies in animal models are required. It can be hoped that an efficient and safe artificial pancreas would be available within a decade.
Kalaeidoscope-a great health blog
Fetching RSS feed... please stand byFeedback
Like this lens? Want to share your feedback, or just give a thumbs up? Be the first to submit a blurb!
Links
- BBC NEWS
- UK children with type 1 diabetes are being recruited to test an artificial pancreas next year.
- Make a Donation : Juvenile Diabetes Research Foundation International
- Help the diabetes cause-Donate!
- Gomez Peer
- Gomez Peer helps you to earn with just your Internet connection!
(by 1 person)












